News & Analysis on Clinical Trial Services & Contract Research And Development
Clarify Health Solutions
By Melissa Fassbender
- Last updated on
Kara Dennis has been appointed senior vice president and general manager of life sciences at Clarify Health.
In her role, Dennis will be responsible for spearheading the company’s new business division, leading the development of new offerings. According to the company, the new division will focus on “closing the data gap to improve patient outcomes for emerging therapies and personalized medicine.”
Dennis previously was managing director of mobile health at Medidata Solutions, before which time she spent four years in McKinsey & Co's healthcare practice.
“I believe we can provide life sciences companies with actionable and scalable insights on what patients are experiencing on a day-to-day basis as well as over the course of their care journeys, and that these insights will help improve workflows and operational efficiencies, the patient experience and, ultimately, patient outcomes,” Dennis told us.
Dennis said the company frequently hears from its biopharma clients that they don't understand something critically important about their patient population:
“In some instances, their patients should be taking a biologic but they're not, and it's not clear why. In other instances, even when a patient is prescribed a proven therapy, the disease seems to be poorly controlled and the reasons for this aren't well understood. We hope to pull together complex healthcare data in a way that provides a clear picture of the whole patient journey,” she explained.
“Another reason why I’m thrilled to be at Clarify Health is that I believe we can help the industry advance models that support the development of groundbreaking therapies,” said Dennis, citing the work takin place in immuno-oncology, gene therapies, biologics, rare disease, and other areas.
“In many of these areas, biopharmaceutical companies will need new approaches to articulating therapeutic value and contracting with payers in order to support the ongoing work being done to get these much-needed innovations to patients, and I think that Clarify can play a critical role in supporting these efforts,” she added.